2019 PRELIMINARy Conference Program


WEDNESDAY, September 25, 2019  

1:00 pm - 2:00 pm

Welcome

Ton Schumacher, Netherlands Cancer Institut, Amsterdam, The Netherlands

2:00 pm - 4:00 pm

Session 1: Cancer prevention and life style factors in oncoimmunology

Session Chairperson: to be announced

Olivera Finn, University of Pittsburgh Cancer Institut, Pittsburgh, Pennsylvania
Title to be announced

Guido Kroemer, Centre de Recherche des Cordeliers, Paris, France
Title to be announced

Yuting Ma, Suzhou Institute of Systems Medicine, Suzhou, China
Title to be announced

4:00 pm - 4:30 pm

Coffee break

4:30 pm - 6:30 pm

Session 2: Combination therapies with immune checkpoint blockers

Session Chairperson: to be announced

Alexander Eggermont, Gustave Roussy Cancer Center, Villjuif, France
Title to be announced

Elizabeth Jaffee, Johns Hopkins School of Medicine, Baltimore, Maryland
Title to be announced

Cornelis J.M. Melief, Leiden University Medical Center and ISA Pharmaceuticals BV, Leiden, The Netherlands
Title to be announced

starting from 6:30 pm

Cocktail reception


THURSDAY, SEPTEMBER 26, 2019

8:00 am - 9:00 am

William B. Coley Lecture

to be announced

9:00 am - 11:00 am

Session 3: T cell exhaustion – mechanisms: RESISTANCE MECHANISMS           

Session Chairperson: to be announced

W. Nicholas Haining, Dana-Farber Cancer Institute, Boston, Massachusetts
Title to be announced

Dietmar Zehn, Technical University of Munich, Freising, Germany
Title to be announced

David Brooks, Princess Margaret Cancer Centre, Toronto, Canada
Title to be announced

11:00 am - 1:00 pm

Session 4: Immunotherapies, non-cell-based

Session Chairperson: to be announced

Ugur Sahin, BioNTech, Mainz, Germany
Title to be announced

Ira Mellman, Genentech, San Francisco, California
Title to be announced

Mario Sznol, Yale Cancer Center, New Haven, Connecticut
Title to be announced

1:00 pm - 3:00 pm

Lunch and Poster Session A and Exhibits

The following topics will be presented:       

  • to be announced

3:00 pm - 4:30 pm

Session 5: Immunotherapies, cell based

Session Chairperson: to be announced

Carl G. Figdor, Radboud University Nijmegen, Nijmegen, The Netherlands
Title to be announced

Helen Heslop, Baylor College of Medicine, Houston, Texas
Title to be announced

Kole Roybal, University of California, San Francisco, California
Title to be announced

4:30 pm - 5:00 pm

Coffee break

5:00 pm - 6.30 pm

Session 6: New targets and concepts

Session Chairperson: to be announced

Ellen Puré, University of Pennsylvania, Philadelphia, Pennsylvania
Title to be announced

Thea Tlsty, University of California, San Francisco, California
Title to be announced

Susan Kaech, Salk Institute for Biological Studies, La Jolla, California
Title to be announced

6:30 pm - 8:00 pm

Drinks and Poster Session A

The following topics will be presented:       

  • to be announced


Friday, SEPTEMBER 27, 2019

9:00 am - 11:00 am

Session 7: Tumor antigens

Session Chairperson: to be announced

Yardena Samuels, Weizmann Institute of Science, Rehovot, Israel
Title to be announced

Robert Schreiber, Washington University School of Medicine, St Louis, Missouri
Title to be announced

John C. Reed, Roche, Basel, Switzerland
Title to be announced

11:00 am - 1:00 pm

Session 8: Vaccination strategies

Session Chairperson: to be announced

Sandra Demaria, Weill Cornell Medical College, New York City, New York
Title to be announced

Sebastian Kreiter, BioNTech AG, Mainz, Germany
Title to be announced

Özlem Türeci, BioNTech AG, Mainz, Germany
Title to be announced

1:00 pm - 3:00 pm

Lunch and Poster Session B and Exhibits

The following topics will be presented:       

  • to be announced

3:00 pm - 4:30 pm

Session 9: New trends in technology & informatics

Session Chairperson: to be announced

Hannah Carter, UC San Diego School of Medicine, La Jolla, California
Title to be announced

John Wherry, Perelman School of Medicine, Philadelphia, Pennsylvania
Title to be announced

Michal Bassani-Sternberg, Lausanne University Hospital, Lausanne, Switzerland
Title to be announced

4:30 pm - 5:00 pm

Coffee break

5:00 pm - 6:30 pm

Session 10: Microbiota in oncoimmunology

Session Chairperson: to be announced

Laurence Zitvogel, Gustave Roussy Cancer Center, Villejuif, France
Title to be announced

Giorgio Trinchieri, National Cancer Institute, Frederick, Maryland
Title to be announced

Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas
Title to be announced

6:30 pm - 8:00 pm

Drinks and Poster Session B

The following topics will be presented:       

  • to be announced


Saturday, September 28, 2019

9:00 am - 11:00 am

Session 11: Onco- and immunometabolism

Session Chairperson: to be announced

Greg Delgoffe, University of Pittsburgh, Pittsburgh, Pennsylvania
Title to be announced

David Munn, Augusta University, Augusta, Georgia
Title to be announced

Ursula Grohmann, University of Perugia, Perugia, Italy
Title to be announced

11:00 am - 1:00 pm

Session 12: TME analysis

Session Chairperson: to be announced

Hervé Fridman, Centre de Recherche des Cordeliers, Paris, France
Title to be announced

Nir Hacohen, Massachusetts General Hospital and Broad Institute, Cambridge, Massachusetts
Title to be announced

Miriam Merad, Icahn School of Medicine at Mount Sinai, New York, New York
Title to be announced

Closing remarks

to be announced